Company / CapEx per Share
Ginkgo Bioworks Holdings, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.14
FY2025
5-year range
$0.02 / $1.25
FY2021-FY2025
Trend
-88.7%
vs FY2024
Sector context
#50 of 190
Health Care
What the data says
At $0.14, Ginkgo Bioworks Holdings, Inc.'s capex per share ranks #50 of 190 in the Health Care sector. CapEx per Share has fluctuated over the past 7 years, ranging from $0.02 in FY2019 to $1.25 in FY2024.
Based on SEC 10-K filings.
0.14 in FY2025 with a 5-year CAGR of +25.5%.
Improved from $0.02 to $0.14 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +63.2%
- 5-Year CAGR
- +25.5%
- 10-Year CAGR
- -
Sector benchmark
#50 of 190 in Health CareTop 26% of 190This company $0.14 Sector average $2.49
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 88.7% year-over-year.
- Ranks #50 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | -88.7% |
| FY2024 | $1.25 | +5696.3% |
| FY2023 | $0.02 | -33.5% |
| FY2022 | $0.03 | -26.0% |
| FY2021 | $0.04 | -3.3% |
| FY2020 | $0.05 | +134.6% |
| FY2019 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026